PAREXEL has expanded its Managed Access Program service for the design, development, and delivery of managed access programs, which help biopharma companies provide investigational products to patients in need.   Managed Access Programs provide use of an investigational medical product by a patient when enrollment in a clinical trial is not possible and allows patients to obtain direct access to a therapy while regulatory or reimbursement processes are still ongoing.    “Managed Access Progr...